1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-KH8365 |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Knockout Stable Cell Line |
Host Cell | HEK293; HeLa or other cell lines |
Human LDLR knockout cell line is edited by CRISPR/Cas9 technology.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
The objective is to create a human LDLR knockout cell line using CRISPR/Cas-mediated genome engineering. The knockout model can be used for studying LDLR’s role in cholesterol metabolism and other related cellular functions.
Exon 2 of the LDLR gene was selected as the target site for the knockout. This exon contains important coding regions, making it an effective target for disrupting the LDLR function.
PCR and sequencing are used to confirm the knockout of the LDLR gene. Clones are screened, and the regions containing the mutation are sequenced to verify the genotype.
The LDLR knockout cell line is generated through CRISPR/Cas-mediated genome engineering. Single clones are isolated and screened, followed by genotyping. Successful knockout clones are cryopreserved.
The cells are stored in liquid nitrogen vapor phase. The recommended culture conditions include 95% air and 5% CO₂ at 37°C. The cells are cultured in basal medium, supplemented with 10% Fetal Bovine Serum (FBS).